GENOTYPE AT HIGHER RISK DUE TO EXCESSIVE OMEGA-6 – (01-14-04)



Arachidonate 5-Lipoxygenase Promoter Genotype, Dietary Arachidonic Acid, and Atherosclerosis

The whole idea that every patient can be treated with blanket recommendations and everyone has the same RDI for vitamins has become old hat. We now have identifed many genetic uniquenesses that correlate with risk of disease process.

This study found a specific genotype that was at greater risk of inflammation from too much omega-6 vs omega-3. What happens if we go back to the ideas of the old research studies in light of what we now know? Will those studies evaluating fat intake and chronic disease show a striking increase in risk if we stratify for these genetic uniquenesses?? I would believe strongly that this would be the case.

NEJM — Arachidonate 5-Lipoxygenase Promoter Genotype, Dietary Arachidonic Acid, and Atherosclerosis –

Read entire article here

 

James Bogash

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email:



Posted on
Categories: Inflammation, Vitamins
Disclosure of Material Connection: Some of the links in the post above are “affiliate links.” This means if you click on the link and purchase the item, I will receive an affiliate commission. Regardless, I only recommend products or services I use personally and believe will add value to my readers. I am disclosing this in accordance with the Federal Trade Commission’s 16 CFR, Part 255: “Guides Concerning the Use of Endorsements and Testimonials in Advertising.”